|
|
 |
|
Viewing report
|
|
|
|
Pharmacogenetics: Opportunities and Challenges for Health Innovation
OECD Publishing, Dec 2009, Pages: 132
Pharmacogenetics helps us understand the relationship between an individual’s genetic make-up and the way medicines work for each person. This book reviews the use of pharmacogenetics across all stages of the health innovation cycle from research through to uptake by doctors and patients. It focuses on how to optimise the use of pharmacogenetics to deliver effective innovations for public health, and design policies that enhance their economic and social benefits.
The book argues for large-scale studies to validate the biomarkers that underpin pharmacogenetics and policies to share the cost and risk of using pharmacogenetics to improve the use of existing medicines. Governments and others need to align regulatory, reimbursement and other incentives and work with industry to measure better the impacts of pharmacogenetics. Health systems need to take positive steps to adapt to the use of pharmacogenetics and ensure that health professionals receive adequate training.
Customers who bought this item also bought
A Quick Guide to Clinical Trials for People Who May Not Know It All
Driving Drug and Diagnostic R&D: The Undeniable Influence of Biomarkers
Biomarkers - Technologies, Markets and Companies
Personalized Medicine: Companies, Trends and World Market
How to Get Ahead with Pharmacogenomics
Cell Therapy - Technologies, Markets and Companies
Enabling Innovation: Drug Development Through Biomarker Validation and Qualification
Proteomics - Technologies, Markets and Companies
Gene Therapy - Technologies, Markets and Companies
RNAi - Technologies, Markets and Companies
|
|
|
|
